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Controlling the transmission of biochemical information across phospholipid bilayers is an enormous opportunity in synthetic biology. Artificial signal transduction would allow orthogonal signalling pathways to be introduced into cells, "short-circuiting" their signalling networks, or would facilitate communication between compartments 1 in artificial tissues. 2 Cellular signal transduction is largely mediated by three classes of membrane proteins: tyrosine kinase receptors, ligand-gated channels and (most abundantly) G proteincoupled receptors (GPCRs). Efforts have been made to replicate the mode of action of first two, [3] [4] [5] [6] but mimics of GPCRs, which offer the greatest scope for use in synthetic biology, have proved elusive. While many structural details of GPCRmediated signal transduction are poorly understood, 7 a general mechanism is clear. 8, 9 GPCRs, which comprise seven transmembrane helices, adopt a number of interchanging conformational states in the membrane. 10, 11 Selective binding of an appropriate signalling ligand at a site exposed to the extracellular medium induces a local conformational preference in the tertiary structure of a receptor, which propagates through the GPCR and across the bilayer to the cytosolic terminus >4 nm distant. 12 This new conformational state, which predominates over the others, initiates the signalling cascade. Synthetic molecules have been designed that have functional analogy with ligand-activated GPCRs like the β2 adrenoreceptor, 1 but they work only in organic solvents. [13] [14] [15] [16] Results and Discussion Design of the receptor mimic. We set out to design and construct a synthetic molecular structure exhibiting the 'minimal' essential design features required for a functional mimic of a ligand-activated GPCR. The key aspects of the design are shown in Fig. 1 . It has the following features: (i) a hydrophobic scaffold (Fig.  1b , shown in grey) that inserts into a phospholipid bilayer and has molecular dimensions commensurate with bilayer width; (ii) two interconverting conformational states that are perturbed by binding of a chiral ligand to a binding site; (iii) a binding pocket (Fig. 1b, green) with a metal(II) ion cofactor that allows strong, reversible, and shape-selective binding of aqueous ligands (Fig. 1b, red) at the bilayer interface, even in the presence of water; (iv) a remote group that gives a detectable spectroscopic response to changes in conformational state (Fig. 1b, blue) .
As the molecular scaffold forming the core of the receptor, we chose a structural motif characteristic of peptaibols, 17 fungal antibiotics that insert into and permeabilise membranes. Peptaibols are rich in the quaternary amino acid α-aminoisobutyric acid (Aib), which induces them to fold into helical conformations with hydrophobic character. Synthetic oligomers built solely from Aib fold into 310 helices (Figure 1a , "Relay"), 18 with decamers being sufficiently long to span a bilayer. 19 In solution, these "foldamers" 20 populate almost exclusively 21 two rapidly exchanging conformational states of left or right handed helical screw sense, with the relative population of these two states being remarkably sensitive to chiral influences. [22] [23] [24] [25] A chiral ligand covalently 15 or non-covalently 16 bound to one terminus of an Aib foldamer will propagate its conformational influence through the entire foldamer length. 26 In this way endto-end transmission of binding information over multi-nanometre distances has been accomplished through Aib foldamers dissolved in organic solvents. 15, 27, 28 Recently, covalently controlled conformational switching over multi-nanometre distances within membrane-bound Aib foldamers was demonstrated using a light-switchable molecule. 29 The ligand binding pocket was constructed from a cationic metal(II) bis(2-quinolylmethyl)(2-pyridylmethyl)amine (BQPA) complex (Fig. 1a , "Input"). 30 Complexation of a chiral guest (such as a carboxylate, Fig. 2a ) in acetonitrile induces the achiral BQPA-metal complex to adopt preferentially one of two mirror-image (M or P) propeller-shaped conformations. 31 To validate foldamer-linked Cu-BQPA as a conformationally responsive binding site, incremental amounts of enantiomeric ligands Boc-L-Pro (L-2a) or Boc-D-Pro (D2a) in CH3CN were added to Cu-3 bearing an N-terminal copper(II) BQPA complex ( Supplementary Fig. 4.11 ). Equal and opposite changes in the Cotton effect at 239 nm were observed, confirming tight binding (Kd < 1 μM) of these prototypical chiral ligands to the metal ion and induction of chirality in the BQPA binding pocket (Fig. 2f ).
Pyrene fluorescence was used to detect the conformational response of the receptor mimic when embedded in a vesicle membrane. Other analytical techniques typically used for conformational analysis of foldamers in solution [14] [15] [16] were found to be ill-suited to the membrane phase and/or Cu(II) ions. Pyrene has a monomer fluorescence emission at 378 nm, and depending on their proximity and relative orientation, a pair of pyrene fluorophores may form an excimer that emits at 450 nm. 13 A ratiometric fluorescent probe of conformation was synthesised (Fig. 1a , "Output") by incorporating two pyrene units into a chiral diamine, which was ligated to the terminus of an Aib oligomer. The two helical screw-sense conformations of the Aib foldamer were expected to induce diastereoisomeric conformations in the fluorophore (Figure 1b , in blue), each with a characteristic ratio of excimer to monomer emission (E/M ratio). Fluorescence spectroscopy of a series of Aib foldamers bearing covalently linked N-terminal chiral residues showed a clear dependence of the E/M ratio on the ratio of screw-sense populations in solution (see Supplementary Fig. 4 .10), with an increase in the proportion of P helix causing an increase in E/M.
Function of the receptor mimic in solution.
The synthesis of receptor 1 builds a structure that has these three components -a binding site, a signal relay and a fluorescent reporter (Fig. 1) . After adding the copper(II) cofactor, the resulting complex Cu-1 was treated with a pair of enantiomeric carboxylates in acetonitrile solution (Fig. 2a,b) . Adding incremental amounts of Boc-L-Pro (L-2a) and Boc-D-Pro (D-2a) in CH3CN caused changes in both the CD and fluorescence spectra (Fig. 2c-e ) not seen in a control Aib foldamer 4 lacking the Cu(BQPA) binding pocket ( Fig. 2g and Supplementary Fig. 4.11) . Crucially, the enantiomers L-2a and D-2a gave opposite responses; L-2a induced positive ellipticity at 239 nm, an increase in excimer emission and an increase in E/M ratio (from 1.65 to 1.82), whereas D-2a induced negative ellipticity, a decrease in excimer emission and a decrease in E/M (from 1.65 to 1.42). These parallel spectral changes indicate firstly that a local chiral preference is induced in the BQPA binding site (giving rise to the Cotton effect at 239 nm), and secondly that the conformational preference is transmitted through the helical oligomer to the remote C-terminal fluorophore (inducing a change in excimer fluorescence that produces a change in E/M ratio). Analysis of the CD and excimer emission data using a 1:1 binding model showed tight binding to 1 in CH3CN, providing Kd = 1 µM for D-2a and Kd = 1.7 µM for L-2a.
Function of the receptor mimic in the membrane. With the receptor mimic Cu-1 functioning in an organic solvent, we explored its behaviour in the membrane phase. Vesicles were made from the phospholipid 1,2-dioleoyl-snglycero-3-phosphocholine (DOPC), which at 25 °C gives fluid bilayers 32 that allowed Cu-1 the conformational freedom to respond to ligand binding. DOPC bilayers also have a hydrophobic thickness of 2.88 nm 32 commensurate with the 2.6 nm estimated hydrophobic length of Cu-1. An aliquot of Cu-1 in acetonitrile was added to a suspension of large unilamellar vesicles (LUVs, 800 nm diameter, at pH 7.4) to give vesicles with 0.4 mol% Cu-1, a low loading that minimised inter-receptor contacts. A rapid >100-fold increase in fluorescence occurred (Fig.  3b,c) , consistent with insertion of a pyrene moiety into a bilayer. 33 This increase in emission stabilised after 25 minutes, leading to steady value of E/M = 1.25 (Fig. 3c) . A similar value for E/M was found for membrane loadings from 0.2 to 1 mol% ( Supplementary Fig. 6.3) , suggesting that at these loadings intermolecular excimer formation due to aggregation is not significant. Incorporation of Cu-1 into bilayers was confirmed by fluorescence microscopy (Fig. 3d) , which showed pyrene excimer fluorescence localised in the LUVs. The fluorescence emission from Cu-1 in buffer alone was much weaker than the emission from membraneembedded Cu-1 (see Supplementary Information Section 6.5.1), allowing the effect of any non-inserted Cu-1 to be disregarded.
The conformational responsiveness of membrane-bound Cu-1 was explored by adding carboxylate ligands to the suspension of vesicles. As in isotropic solution, the addition of chiral ligands L-2a and D-2a (Fig. 4a) to Cu-1 in a bilayer produced changes in its fluorescence spectrum, although much higher concentrations of ligand (100 times greater) were required to achieve a similar level of response. Intriguingly the membrane environment reversed the conformational response of the pyrene probe, indicating that an increase in E/M now corresponds to an increase in the proportion of M helix. This reversal of fluorescent response also occurred for covalently controlled foldamers in bilayers ( Supplementary Fig. 5.1 ) whereas the CD titration of Cu-3 in bilayers with L-2a, which gave a positive signal at 239 nm ( Supplementary Fig. 6 .6.1), showed that the induction of screw sense at the BQPA binding site occurred with the same sense as in solution (Fig. 2f) . Since opposite enantiomers of 2a still induced opposite responses in Cu-1 (L-2a decreasing and D-2a increasing the excimer emission intensity and the E/M ratio), a generalised ligand-induced change in bilayer properties could be ruled out as the origin of the fluorescence modulation. Additionally, homologous foldamers with shorter Aib chains (Aib4 in place of Aib8) showed no fluorescent response, not only confirming that there is no direct interaction between ligand and fluorophore but also suggesting that higher hydrophobicity may promote deeper membrane insertion that is required for function. Fitting the changes in Cu-1 excimer emission to a 1:1 binding model confirmed that binding of these agonists to membrane-bound Cu-1 was 100-fold weaker than in CH3CN solution (L-2a gave Kd ≈ 140 µM; D-2a gave Kd ≈ 60 µM). The half maximal effective concentration (EC50) values, which are commonly used 34 to quantify responses of membrane-bound receptors, were calculated by fitting the changes in E/M. This provided EC50 = 130 ± 30 µM and 70 ± 30 µM for L-2a and D-2a respectively.
It was not possible to assign with confidence the precise orientation of the foldamer in the bilayer. The ability of the polar carboxylate ions to enter the binding site implies this polar Cu(II)-bearing moiety is exposed to the aqueous environment surrounding the vesicles. Comparing the ratio of monomer emission intensities from the I and III emission bands from the pyrene fluorophore 35 of Cu-1 in organic solvents to Cu-1 in a bilayer indicates that the pyrenes are in a polar environment to which water has access. This suggests that the pyrenes lie within the membrane but close to the interface with water, possibly on the other side of the bilayer (foldamers of similar length and structure are capable of spanning the bilayer 19 ).
Other carboxylates appeared to bind within the pocket, such as unprotected Lproline (EC50 ~ 130 µM), but these agonists had lower efficacy and only induced very weak conformational responses in membrane-embedded Cu-1. Glutamate and aspartame induced no change in fluorescence, although another Bocprotected amino acid, Boc-L-Leu L-2c, induced a decrease in E/M (EC50 = 40 ± 20 µM), albeit more weakly than L-2a. Binding seemed to translate into a remote conformational response only with carboxylate ligands containing an amide-like carbonyl group, probably through hydrogen bonding to an adjacent Aib residue in the helical oligomer (see Fig. 1a and Supplementary Fig. 6.7.4 ). With this in mind, Leu-enkephalin (Tyr-Gly-Gly-Phe-Leu, 2d), an endogenous opioid peptide neurotransmitter that binds μ-and δ-opioid GPCRs, 36 was tested. Remarkably we found that Leu-enkephalin (EC50 = 70 ± 30 µM) induced a powerful response in our receptor mimic, increasing E/M significantly.
Carboxylate ligand binding to membrane-bound Cu-1 is reversible, and this feature was demonstrated using competitive binding between an "agonist" and an "antagonist". Addition of the "agonist" Leu-enkephalin 2d resulted in an increase in E/M in Cu-1, which could be reversed and then inverted by competitive binding of the "antagonist" L-BocPro L-2a (Fig. 4c) . Ligand L-2a thus behaves in a manner analogous to μ-and δ-opioid GPCR antagonists such as naloxone. 37, 38 Conclusions.
Designed synthetic molecules 1 are far simpler than biological receptors of the GPCR family, yet they display all the characteristics required of a functional, synthetic, 'minimal' receptor. They embed themselves into a membrane, they exhibit selective and competitive binding of certain classes of ligand at a welldefined binding site, they change conformation as a result of ligand binding, and the resulting conformational change is transmitted through the receptor to a site remote from the binding site. Cu-1 and its congeners offer a rare opportunity to compare the conformational behaviour of a molecule in solution and in the membrane phase, and to probe the effect of the membrane on conformational preference and ligand binding. Receptor 1 is of a length comparable with the thickness of a typical cell membrane, and we are currently exploring the possibility of using its metal complexes to transmit chemical information through a membrane barrier, with the aim of controlling functional behaviour in artificial vesicles, and ultimately even in living cells. 
